Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Eye

• Publication date

  2016-05-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/eye.2016.96PMID 27229707PMCID PMC4985687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion

  2013cited by this paper
• OPTICAL COHERENCE TOMOGRAPHY IN RETINITIS PIGMENTOSA: Reproducibility and Capacity to Detect Macular and Retinal Nerve Fiber Layer Thickness Alterations

  2012cited by this paper
• Economic considerations of macular edema therapies.

  2011cited by this paper
• Incidence of Increased Intraocular Pressure after Subtenon Injection of Triamcinolone Acetonide

  2011cited by this paper
• A Comparison of Three Different Intravitreal Treatment Modalities of Macular Edema Due to Branch Retinal Vein Occlusion

  2010cited by this paper
• Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application.

  2010cited by this paper
• AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS ARE ASSOCIATED WITH SEROUS MACULAR DETACHMENT SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

  2010cited by this paper
• Natural history of branch retinal vein occlusion: an evidence-based systematic review.

  2010cited by this paper
• Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

  2010cited by this paper
• The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.

  2010cited by this paper
• Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.

  2009cited by this paper
• Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up

  2009cited by this paper
• A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

  2009cited by this paper
• COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: Results From the Pan-American Collaborative Retina Study Group at 6 Months of Follow-Up

  2008cited by this paper
• Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities

  2008cited by this paper
• Pharmacokinetics of intravitreal bevacizumab (Avastin).

  2007cited by this paper
• INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

  2007cited by this paper
• Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.

  2007cited by this paper
• Frequency and Risk Factors for Intraocular Pressure Elevation After Posterior Sub-Tenon Capsule Triamcinolone Acetonide Injection

  2007cited by this paper
• Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study.

  2006cited by this paper
• Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion

  2006cited by this paper
• Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.

  2005cited by this paper
• Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide

  2005cited by this paper
• Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.

  2005cited by this paper
• Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.

  2005cited by this paper
• INTRAVITREAL TRIAMCINOLONE AS PRIMARY TREATMENT OF CYSTOID MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

  2005cited by this paper
• Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

  2001cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

  1998cited by this paper
• Blood-retina barrier in acute retinal branch vein occlusion

  1995cited by this paper
• Temporal branch retinal vein obstruction: a review.

  1986cited by this paper
• Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.

  1983cited by this paper
• The natural course of temporal retinal branch vein occlusion.

  1974cited by this paper
• Clinical Ophthalmology Dovepress Dovepress

  year unknowncited by this paper

• The efficacy and safety of intraocular anti-VEGF injections versus anti-VEGF combined with steroids or steroid monotherapy for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis of randomized controlled trials

  2026cites this paper
• Safety and efficacy of anti-vascular endothelial growth factor (VEGF) plus corticosteroids versus anti-VEGF alone for macular edema from retinal vein occlusion: A systematic review and meta-analysis.

  2026cites this paper
• Randomized study evaluating the efficacy of sustained-release dexamethasone with or without prompt laser for branch retinal vein occlusion-related macular edema

  2025cites this paper
• Risk of intraocular pressure elevation associated with triamcinolone acetonide administration via different routes in macular edema: a systematic review and network meta-analysis of randomized controlled trials

  2025cites this paper
• Effectiveness and cytokine profile of combined anti-vascular endothelial growth factor and corticosteroid therapy for chronic retinal vein occlusion

  2025cites this paper
• Short-Term outcomes in patients with center-involving diabetic macular edema after a single dose of Intravitreal Bevacizumab.

  2025cites this paper
• Progress in Treatment of Macular Edema Secondary to Retinal Vein Occlusion

  2025cites this paper
• Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis

  2023cites this paper
• Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema

  2022cites this paper
• Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis

  2022cites this paper
• Effect of Supra-Choroidal Triamcinolone Injection on Best-Corrected Visual Acuity and Central Retinal Thickness in Patients with Macular Edema Secondary to Retinal Vein Occlusion

  2021cites this paper
• Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion

  2020cites this paper
• One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion

  2020cites this paper
• Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.

  2020cites this paper
• Implication of inflammatory cytokines in the aqueous humour for management of macular diseases

  2020cites this paper
• Combined Ranibizumab and Subtenon Triamcinolone Injection for Macular Edema Secondary to Branch Retinal Vein Occlusion

  2019cites this paper
• Combined Treatment with Intravitreal Bevacizumab and Intravitreal Triamcinolone in Retinal Vein Occlusion in Indian Eyes

  2019cites this paper
• Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan

  2019cites this paper
• Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab in Macular Edema Secondary to Retinal Vein Occlusion

  2019cites this paper
• Choroidal Changes after Suprachoroidal Injection of Triamcinolone in Eyes with Macular Edema Secondary to Retinal Vein Occlusion

  2018cites this paper
• Same Day Sub-tenon’s Triamcinolone and Anti-VEGF Injections in Patients with Macular Edema Secondary to Central Retinal Vein Occlusion

  2018cites this paper
• The Use of Intravitreal Anti-VEGF and Triamcinolone in the Treatment of Radiation Papillopathy

  2018cites this paper
• Effect of funding source on reporting bias in studies of intravitreal anti‐vascular endothelial growth factor therapy for retinal vein occlusion

  2018cites this paper
• Comparison between anti‐VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta‐analysis

  2017cites this paper
• Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.

  2017cites this paper